Currently, there is good scientific documentation of the capacity for low-dose CT to detect lung cancer at an early stage. There is no scientific documentation to show how mortality would be affected by an organized program using low-dose CT for early detection of lung cancer. There is poor documentation on the cost effectiveness of the method.
Before considering the appropriateness of routine screening for lung cancer, a positive effect on mortality must be demonstrated by large, controlled trials of screening programs.